ROMVIMZAPriority claimed from 25/10/2023; Application No. : 98238958 ;United States of America (Class 5)
#6402495
Application Number:6402495
Status: Unknown
Class:5
Applicant:Deciphera Pharmaceuticals, LLC
Filing Date:Wed, 24 Apr 2024
In Progress
Is this your trademark application?
"ROMVIMZAPriority claimed from 25/10/2023; Application No. : 98238958 ;United States of America" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.
Trademark Information
| Trademark | ROMVIMZAPriority claimed from 25/10/2023; Application No. : 98238958 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 6402495 |
| Nature/Scope of business | Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors. |
| Publication | In Journal No. 2178 |
| Status | Unknown |
| Applicant: | Deciphera Pharmaceuticals, LLC |
| Applicant Address | 200 Smith Street, Waltham, Massachusetts 02451, United States of America A Delaware Limited Liability Company |
| Jurisdiction | DELHI |
| Agent | LALL & SETHI |
| Agent Address | D-17, South Extension Part II, New Delhi 110049, India |
Frequently Asked Questions
Who is the owner of trademark ROMVIMZAPriority claimed from 25/10/2023; Application No. : 98238958 ;United States of America? ▾
The trademark application number 6402495 is owned by Deciphera Pharmaceuticals, LLC.
Which class does trademark ROMVIMZAPriority claimed from 25/10/2023; Application No. : 98238958 ;United States of America belong to? ▾
Trademark application number 6402495 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 6402495? ▾
The trademark agent associated with application number 6402495 is LALL & SETHI.
Was trademark ROMVIMZAPriority claimed from 25/10/2023; Application No. : 98238958 ;United States of America published in the journal? ▾
Yes, trademark application number 6402495 was published in Journal No. 2178.
What is trademark ROMVIMZAPriority claimed from 25/10/2023; Application No. : 98238958 ;United States of America? ▾
Trademark application number 6402495 relates to "Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors.".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified